Abirapro 250mg Tablet (Abiraterone Acetate 250mg)
Abirapro 250mg Tablets (Abiraterone Acetate) are a trusted oral chemotherapy medication used for treating advanced prostate cancer in the United State United States, Phoenix, Houston, Chicago, Los Angeles, New York City, Canada, Toronto, Vancouver, Montreal, Regional Focus β North & South USA, Israel β Jerusalem (IL)s. Abirapro 250mg Tablets (Abiraterone Acetate) are a trusted oral chemotherapy medication used for treating advanced prostate cancer in the United State Manufactured under GMP standards, Abirapro ensures safety, efficacy, and global export quality. Available for importers, distributors, and oncology care centers in Washington D.C. and across the USA, this product supports effective cancer management with international-grade packaging and quality assurance.
Composition:
Abiraterone Acetate 250mg
onsume Type:
Oral
Storage:
Store below 30Β°C in a cool, dry place away from direct sunlight.
@ERNESTPHARMACEUTICALPVTLTD
For bulk quotations, availability, and orders, please contact us:
π§ Email: exports@ernestpharmaceuticals.com
π www.ernestpharmaceuticals.com| www.ernestimpex.com
Amit Rai: WhatsApp link https://wa.me/message/M6GESWXSIOZMD1
π² WhatsApp: +91 94054 76170
Product Description
Abirapro 250mg Tablet is an oral anti-cancer medication belonging to the class of hormonal therapy drugs used primarily in the treatment of metastatic prostate cancer. It is prescribed for men whose prostate cancer has spread to other parts of the body and continues to progress despite medical or surgical castration.
The tablet contains Abiraterone Acetate (250mg), which works by inhibiting the enzyme CYP17, a critical component in the production of androgens (male hormones such as testosterone). Since prostate cancer cells rely on these hormones for growth, Abirapro helps reduce androgen levels, thereby slowing down or stopping cancer progression.
Uses of Abirapro 250mg Tablet
Treatment of metastatic prostate cancer (advanced stage).
Used in combination with prednisone or prednisolone as part of hormone therapy.
Mechanism of Action
Abirapro 250mg Tablet works by blocking CYP17 enzyme activity, which decreases androgen production in the testes, adrenal glands, and tumor tissues. This reduction in androgen levels starves prostate cancer cells of the hormones they need to grow and multiply, effectively controlling the disease and improving survival outcomes.
Dosage and Administration
Take Abirapro 250mg Tablet on an empty stomach β at least 1 hour before or 2 hours after a meal.
Swallow the tablet whole with water; do not crush or chew.
The dosage and duration are determined by your doctor based on your condition and response to treatment.
Do not discontinue treatment without consulting your healthcare provider.
Common Side Effects
Like all medications, Abirapro 250mg Tablet may cause side effects, which are generally manageable and reversible with medical guidance.
Common side effects include:
Fatigue and weakness
Edema (swelling)
Vomiting and nausea
Hypertension (high blood pressure)
Decreased potassium levels
Anemia
Joint swelling or pain
Increased blood glucose levels
Urinary tract infection
Serious side effects:
Liver dysfunction symptoms such as yellowing of skin or eyes, dark urine, persistent nausea, and abdominal pain should be reported immediately to your doctor.
Precautions and Warnings
Allergy: Avoid use if you are allergic to Abiraterone or any component of the formulation.
Pregnancy: Not recommended for use in women. It is contraindicated during pregnancy due to potential fetal harm.
Liver Impairment: Use with caution; liver function tests should be regularly monitored.
Kidney Impairment: Use under medical supervision.
Alcohol: Avoid alcohol consumption unless approved by your doctor.
Contraception: Effective contraception is advised for both male and female partners during and after treatment.
Safety Advice
Driving: Abirapro does not usually impair your ability to drive.
Diet: Take on an empty stomach. Maintain a balanced diet to support treatment.
Monitoring: Regular monitoring of liver enzymes, blood pressure, potassium, and glucose levels is advised during therapy.